P534: AZACITIDINE PLUS VENETOCLAX FOR THE TREATMENT OF RELAPSED AND FIRST-LINE AML PATIENTS

• S. Garciaz,
• M.-A. Hospital,
• A.-S. Alary,
• C. Saillard,
• Y. Hicheri,
• B. Mohty,
• J. Rey,
• E. D’incan,
• A. Charbonnier,
• V. Ferdinand,
• V. Maisano,
• L. Lombardi,
• A. Ittel,
• M.-J. Mozziconacci,
• V. Gelsi-Boyer,
• N. Vey

Affiliations

S. Garciaz

1 Hematology

M.-A. Hospital

1 Hematology

A.-S. Alary

2 Molecular biology

C. Saillard

1 Hematology

Y. Hicheri

1 Hematology

B. Mohty

1 Hematology

J. Rey

1 Hematology

E. D’incan

1 Hematology

A. Charbonnier

1 Hematology

V. Ferdinand

1 Hematology

V. Maisano

1 Hematology

L. Lombardi

1 Hematology

A. Ittel

3 Biopathology, Institut Paoli-Calmettes, MARSEILLE, France

M.-J. Mozziconacci

3 Biopathology, Institut Paoli-Calmettes, MARSEILLE, France

V. Gelsi-Boyer

3 Biopathology, Institut Paoli-Calmettes, MARSEILLE, France

N. Vey

1 Hematology